Skip to content
Naweekaktueel episode artwork

Nov 30, 2019 4 min

Naweekaktueel

from Naweekaktueel Hosted by RSG

In die been van ons reeks oor intellektuele eiendom en toegang tot goedkoper medikasie, kyk ons wat gebeur wanneer 'n nuwe middel die mark tref. Ons fokus onder meer op Bedaquiline en Delaminid, wat van die nuwe middels is in die stryd teen meervoudige middelweerstandige TB. Marlinee Fouche berig dat die bekendstelling van nuwe middels nie veel beteken, as verskeie ander faktore wat deel vorm van diagnose en behandeling, nie reeds in gebruik geneem is nie.

Episode details come from the podcast's RSS feed.

Embed this episode

Ready to play

Naweekaktueel

0:00 4:18

No transcript yet.

Requests help us decide what to transcribe next.

Frequently asked questions

How long is this episode of Naweekaktueel?

This episode is 4 minutes long.

When was this Naweekaktueel episode published?

This episode was published on November 30, 2019.

Can I download this Naweekaktueel episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.